Related by context. Frequent words. (Click for all words.) 66 pharmacodynamic effects 66 optimal dosing 65 pharmacokinetic parameters 65 refractory chronic lymphocytic 64 pertuzumab 64 nab paclitaxel 64 systemically administered 63 recurrent glioblastoma multiforme 63 tumor lysis syndrome 63 primary hypercholesterolemia 63 predictive biomarkers 63 adecatumumab 63 R sorafenib tablets 63 forodesine 63 teriflunomide 62 neoadjuvant 62 selective inhibition 62 phase Ib 62 pharmacokinetics PK 62 Pharmacologic 62 HGS ETR2 62 Dasatinib 62 6R BH4 62 GRNCM1 62 coadministration 62 phase IIb clinical 62 Acute Ischemic Stroke 62 painful diabetic neuropathy 62 irbesartan 62 intravesical 62 efficacy tolerability 62 eprotirome 62 ALN TTR 62 Pivotal Phase 62 CCX# 62 vorinostat 61 rNAPc2 61 KRN# 61 lipid parameters 61 CORT # 61 nephrotoxicity 61 Factor VIIa 61 Phase Ib II 61 J Am Coll 61 APTIVUS 61 tanespimycin 61 APTIVUS r 61 Natalizumab 61 Trofex 61 immunohistochemical 61 Dapagliflozin 61 Sapacitabine 61 anti fibrotic 61 Metastatic Melanoma 61 Panzem R 61 phase IIa clinical 61 REG1 61 mTOR inhibitors 60 Randomized controlled 60 Coadministration 60 chemotherapy induced neutropenia 60 antihypertensive agents 60 Entereg R 60 YOUR LOCAL ANIMAL SHELTER 60 Recombinant Human 60 VKORC1 60 analgesic efficacy 60 KRAS mutation 60 Azedra 60 Chronic Heart Failure 60 OMS# 60 nucleoside reverse transcriptase inhibitor 60 elotuzumab 60 Alfimeprase 60 orBec 60 PEG PAL 60 secondary hyperparathyroidism 60 trastuzumab Herceptin 60 PEG SN# 60 Phenoptin 60 molecular biomarkers 60 poly ADP ribose polymerase 60 patients undergoing percutaneous 60 Denufosol 60 renal toxicity 60 Combination therapy 59 ISTODAX 59 II Clinical Trial 59 mycophenolate mofetil 59 Phase 1b trial 59 relapsing multiple sclerosis 59 intracoronary 59 lipid lowering agents 59 HGS ETR1 59 pimozide 59 safety tolerability pharmacokinetics 59 hemoglobin A1c HbA1c 59 fluvastatin 59 Percutaneous Coronary Intervention 59 antiproliferative 59 arterial thrombosis